SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: OmertaSoldier who wrote (9702)6/16/1998 1:43:00 PM
From: LoLoLoLita  Read Replies (1) of 23519
 
Three questions all the analysts here seem to have missed:

1. Why was it slightly more effective in diabetics than non-diabetics?

2. How effective was placebo in the two groups? Or, did they perhaps have no placebo data because it wasn't a controlled experiment?

3. Endpoint for success was two rounds of intercourse. Wow! That's a new one. If the study ran six months, how many rounds of intercourse did these men report in the 6-month period preceding the study? Even if they reported zero, you need to consider the possibility that there was under-reporting in order to get into the study.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News